This test is most useful if any of these apply to you.
Most of what you breathe leaves no record you can measure. This urine test is one of the few that puts a number on a specific invisible exposure: the pollutant 1,3-butadiene, which drifts out of car exhaust, tobacco smoke, factory emissions, and burning rubber or plastic.
It will not diagnose a disease. What it offers is a recent snapshot of how much of this compound your body has been processing, and higher readings have been repeatedly tied to worse heart, metabolic, kidney, and hearing outcomes in large population studies.
The full name of this molecule is DHBMA (N-acetyl-S-(3,4-dihydroxybutyl)-L-cysteine). It is what remains after your body links 1,3-butadiene to a protective molecule and flushes it out through the kidneys, a normal cleanup route your cells use to neutralize reactive chemicals. In humans, DHBMA makes up roughly 93% of the urinary breakdown products of 1,3-butadiene, which is why it is used to track exposure. 1,3-butadiene itself is classified as a known human carcinogen (IARC Group 1), which is the most firmly established health concern behind tracking exposure to it.
A word on the name, because it causes real confusion. DHBMA is not the same thing as N-acetylcysteine (NAC), the antioxidant supplement people take. They share part of a chemical name, but DHBMA is a waste product your body creates, not something you swallow. A high reading means more pollutant exposure, not more supplement.
This is where the human evidence is cleanest. In a study of 4,430 US nonsmoking adults from a large national health survey (NHANES), people in the highest quarter of DHBMA had systolic blood pressure about 2.46 mmHg higher than those in the lowest quarter (range 1.01 to 3.92 mmHg), and roughly 5% higher odds of having high blood pressure (prevalence ratio 1.05).
What this means for you: the effect on any single person is modest, but it appeared in people who do not smoke, which points to everyday environmental exposure as a quiet contributor to blood pressure worth tracking alongside the number on your cuff.
In a separate analysis of 5,211 US adults, researchers ranked 19 different pollutant breakdown products by how strongly they contributed to heart attack risk. DHBMA carried the single largest weight (0.27), placing it at the top of the list. This is a cross-sectional finding, so it shows a strong association rather than proof that the pollutant caused the heart attacks.
In 5,092 US adults, each doubling of DHBMA was linked to about 1.32% higher fasting blood sugar, roughly 9.20% higher fasting insulin, and about 10.64% higher insulin resistance. Translated into odds, higher DHBMA was tied to about 36% greater odds of insulin resistance (odds ratio 1.36) and about 51% greater odds of prediabetes (odds ratio 1.51).
Using a machine-learning approach on national survey data, higher DHBMA was associated with about twice the odds of chronic kidney disease (odds ratio 1.95, 95% confidence interval 1.38 to 2.76), and it stood out as one of the strongest single predictors in the model. Kidney disease is one of the areas where this marker appears most consistently.
In a study of adults, higher DHBMA was independently linked to worse overall hearing and worse high-frequency hearing, and the link held after adjusting for age, sex, income, blood pressure, and history of occupational noise. 1,3-butadiene is being examined as a possible toxin to the inner ear.
Two more observational studies add to the pattern. In 2,429 adults, higher DHBMA was an independent risk factor for muscle loss (sarcopenia); this study reported about 4.5 times higher odds, while other, larger studies have found more modest increases of roughly 2.4 to 2.7 times. In 3,683 adults, it emerged as a novel risk factor for osteoarthritis, with risk rising in a non-linear way as levels climbed. Both are associations, not proof of cause.
One study of 853 adolescents and young adults is worth attention because it looked at people long before heart disease usually shows up. Higher DHBMA correlated with higher LDL cholesterol, thicker carotid artery walls (an early sign of plaque), more markers of damaged blood-vessel lining, and higher urinary 8-OHdG, a marker of DNA damage from oxidative stress. The signal appears early.
It is tempting to read a high number as a diagnosis. It is not. DHBMA reflects how much 1,3-butadiene you have recently taken in, and the disease links come from population studies where groups with higher exposure also had more of these conditions. Think of the result as an exposure meter, not a verdict on any organ.
There is also a genuine wrinkle in the science. DHBMA is highly sensitive but not very specific. It has a large natural background in urine and, based on isotope-labeling studies, appears to form partly from internal processes whose exact source is still unknown, not only from breathing in the pollutant. This is why a single high reading should be interpreted as a prompt to look at your exposures, not as a fixed number to act on in isolation.
The most important limitation is timing. DHBMA clears quickly, with a urinary half-life of about 10.3 hours, so a single sample reflects roughly the last day of exposure, not your long-term burden. A test the morning after a smoky bar, a long commute, or a workplace shift can read high for reasons that have nothing to do with your usual life.
Because a single urine reading is a snapshot with real day-to-day swings, the trend matters far more than any one value. The useful question is not whether you cross a line on a given morning, but whether your typical level drifts up or down as your environment and habits change.
A practical approach: get a baseline, then repeat in 3 to 6 months if you change something meaningful, such as your commute, your workplace protection, or your exposure to smoke. After that, at least once a year gives you a personal reference to compare against. Confirming a surprising high result with a second collection on a low-exposure day is more informative than reacting to one reading.
Start with the obvious sources. A high reading is a cue to review tobacco smoke exposure, heavy traffic, indoor cooking smoke, and any hobby or job involving fuels, solvents, or burning rubber and plastic. A repeat test on a quieter day helps separate a one-off spike from a steady pattern.
From there, pair it with the labs the disease associations point to: blood pressure, fasting glucose, kidney markers, a lipid panel, and an oxidative-stress marker such as urinary 8-OHdG. If your exposure is occupational, an occupational medicine clinician can interpret the result alongside workplace air data and more specific markers, such as MHBMA, which has less internal background than DHBMA. There is no evidence supporting chelation or detox regimens to remove this compound; the supported action is reducing exposure at the source.
Evidence-backed interventions that affect your NADB level
N-Acetyl (3,4-Dihydroxybutyl) Cysteine is best interpreted alongside these tests.
N-Acetyl (3,4-Dihydroxybutyl) Cysteine is included in these pre-built panels.